Selective Serotonin Reuptake Inhibitors Modify the Effect of β-Blockers on Long-Term Survival of Patients With End-Stage Heart Failure and Major Depression

Journal of Cardiac Failure

Volumn 14, Issue 6, 2008, Pages 456-464

  Tousoulis, Dimitris ^a   Antoniades, Charalambos ^a   Drolias, Apostolos ^a   Stefanadi, Elli ^a   Marinou, Kyriakoyla ^a   Vasiliadou, Carmen ^a   Tsioufis, Costas ^a   Toutouzas, Kostas ^a   Latsios, George ^a   Stefanadis, Christodoulos ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

cardiovascular death; depression; Heart failure; inflammation; serotonin norepinephrine reuptake inhibitors; serotonin reuptake inhibitors

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; C REACTIVE PROTEIN; CARVEDILOL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INTERLEUKIN 6; METOPROLOL; NEBIVOLOL; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; AGED; ANOREXIA; ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFECT; DRUG EFFICACY; DYSPNEA; FATIGUE; FEMALE; FOLLOW UP; HEART FAILURE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; OUTCOME ASSESSMENT; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; STRESS; SURVIVAL TIME;

ADRENERGIC BETA-ANTAGONISTS; ADULT; AGED; AGED, 80 AND OVER; DEPRESSIVE DISORDER, MAJOR; DRUG INTERACTIONS; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SEROTONIN UPTAKE INHIBITORS; SURVIVAL RATE; TIME; TREATMENT OUTCOME;

EID: 47849114014     PISSN: 10719164     EISSN: 15328414     Source Type: Journal    
DOI: 10.1016/j.cardfail.2008.02.015     Document Type: Article

References (33)

1. Carney R.M., Blumenthal J.A., Stein P.K., Watkins L., Catellier D., Berkman L.F., et al. Depression, heart rate variability, and acute myocardial infarction. Circulation 104 (2001) 2024-2028
2. Otte C., Neylan T.C., Pipkin S.S., Browner W.S., and Whooley M.A. Depressive symptoms and 24-hour urinary norepinephrine excretion levels in patients with coronary disease: findings from the Heart and Soul Study. Am J Psychiatry 162 (2005) 2139-2145
3. Empana J.P., Sykes D.H., Luc G., Juhan-Vague I., Arveiler D., Ferrieres J., et al. Contributions of depressive mood and circulating inflammatory markers to coronary heart disease in healthy European men: the Prospective Epidemiological Study of Myocardial Infarction (PRIME). Circulation 111 (2005) 2299-2305
4. Tentolouris C., Tousoulis D., Antoniades C., Bosinakou E., Kotsopoulou M., Trikas A., et al. Endothelial function and proinflammatory cytokines in patients with ischemic heart disease and dilated cardiomyopathy. Int J Cardiol 94 (2004) 301
5. Ferketich A.K., Ferguson J.P., and Binkley P.F. Depressive symptoms and inflammation among heart failure patients. Am Heart J 150 (2005) 132-136
6. Rutledge T., Reis V.A., Linke S.E., Greenberg B.H., and Mills P.J. Depression in heart failure a meta-analytic review of prevalence, intervention effects, and associations with clinical outcomes. J Am Coll Cardiol 48 (2006) 1527-1537
7. Merit-HF Study Group. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in-Congestive Heart Failure (MERIT-HF). Lancet 353 (1999) 2001
8. Cibis-Ii Investigators. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial. Lancet 353 (1999) 9
9. Packer M., Bristow M.R., Cohn J.N., Colucci W.S., Fowler M.B., Gilbert E.M., et al. The USCHFSG. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med 334 (1996) 1349-1355
10. Packer M., Coats A.J.S., Fowler M.B., Katus H.A., Krum H., Mohacsi P., et al., the Carvedilol Prospective Randomized Cumulative Survival Study Group. Effect of carvedilol on survival in severe chronic heart failure. N Engl J Med 344 (2001) 1651-1658
11. Packer M., Fowler M.B., Roecker E.B., Coats A.J., Katus H.A., Krum H., et al. Effect of carvedilol on the morbidity of patients with severe chronic heart failure: results of the carvedilol prospective randomized cumulative survival (COPERNICUS) study. Circulation 106 (2002) 2194-2199
12. The Beta-Blocker Evaluation of Survival Trial I. A trial of the beta-blocker bucindolol in patients with advanced chronic heart failure. N Engl J Med 344 (2001) 1659-1667
13. Pacher P., Ungvari Z., Kecskemeti V., and Furst S. Review of cardiovascular effects of fluoxetine, a selective serotonin reuptake inhibitor, compared to tricyclic antidepressants. Curr Med Chem 5 (1998) 381-390
14. Roose S.P. Depression, anxiety, and the cardiovascular system: the psychiatrist's perspective. J Clin Psychiatry 62 Suppl 8 (2001) 19-23
15. Lorig K., Gonzalez V., and Laurent D. The chronic disease self-management course leader's manual (1997), Stanford University, Stanford (CA)
16. Jiang W., Glassman A., Krishnan R., O'Connor C.M., and Califf R.M. Depression and ischemic heart disease: what have we learned so far and what must we do in the future?. Am Heart J 150 (2005) 54-78
17. Finkel M.S., Oddis C.V., Jacob T.D., Watkins S.C., Hattler B.G., and Simmons R.L. Negative inotropic effects of cytokines on the heart mediated by nitric oxide. Science 257 (1992) 387-389
18. Blum A., and Miller H. Pathophysiological role of cytokines in congestive heart failure. Annu Rev Med 52 (2001) 15-27
19. Pasic J., Levy W.C., and Sullivan M.D. Cytokines in depression and heart failure. Psychosom Med 65 (2003) 181-193
20. Tousoulis D., Antoniades C., Koumallos N., and Stefanadis C. Pro-inflammatory cytokines in acute coronary syndromes: from bench to bedside. Cytokine Growth Factor Rev 17 (2006) 225-233
21. Miller G.E., Stetler C.A., Carney R.M., Freedland K.E., and Banks W.A. Clinical depression and inflammatory risk markers for coronary heart disease. Am J Cardiol 90 (2002) 1279-1283
22. Suarez E.C., Krishnan R.R., and Lewis J.G. The relation of severity of depressive symptoms to monocyte-associated proinflammatory cytokines and chemokines in apparently healthy men. Psychosom Med 6 (2003) 362-368
23. Tsutamoto T., Hisanaga T., Wada A., Maeda K., Ohnishi M., Fukai D., et al. Interleukin-6 spillover in the peripheral circulation increases with the severity of heart failure, and the high plasma level of interleukin-6 is an important prognostic predictor in patients with congestive heart failure. J Am Coll Cardiol 31 (1998) 391-398
24. Drolias A., Tousoulis D., Antoniades C., Tentolouris C., Vasiliadou C., Trikas A., et al. Non-selective serotonin reuptake inhibitors modify inflammatory process in patients with heart failure and depression. Eur Heart J 27 abstract supplement (2006) 230
25. Bayram M., De Luca L., Massie M.B., and Gheorghiade M. Reassessment of dobutamine, dopamine, and milrinone in the management of acute heart failure syndromes. Am J Cardiol 96 Suppl 1 (2005) 47
26. Shannon R., and Chaudhry M. Effect of alpha1-adrenergic receptors in cardiac pathophysiology. Am Heart J 152 (2006) 842-850
27. McMurray J., Cohen-Solal A., Dietz R., Eichhorn E., Erhardt L., Hobbs F.D.R., et al. Practical recommendations for the use of ACE inhibitors, beta-blockers, aldosterone antagonists and angiotensin receptor blockers in heart failure: putting guidelines into practice. Eur J Heart Failure 7 (2005) 710
28. Mann J.J. The medical management of depression. N Engl J Med 353 (2005) 1819-1834
29. Magyar J., Rusznak Z., Harasztosi C., Kortvely A., Pacher P., Banyasz T., et al. Differential effects of fluoxetine enantiomers in mammalian neural and cardiac tissues. Int J Mol Med 11 (2003) 535-542
30. Qvigstad E., Brattelid T., Sjaastad I., Andressen K.W., Krobert K.A., Birkeland J.A., et al. Appearance of a ventricular 5-HT4 receptor-mediated inotropic response to serotonin in heart failure. Cardiovasc Res 65 (2005) 869-878
31. Qvigstad E., Sjaastad I., Brattelid T., Nunn C., Swift F., Birkeland J.A.K., et al. Dual serotonergic regulation of ventricular contractile force through 5-HT2A and 5-HT4 receptors induced in the acute failing heart. Circ Res 97 (2005) 268-276
32. Cohen M.D., Finberg J., Dibner-Dunlap M., Yuih S.N., and Thames M.D. Effects of desipramine hydrochloride on peripheral sympathetic nerve activity. Am J Physiol 258 (1990) R876-R882
33. Ohtani H., Odagiri Y., Sato H., Sawada Y., and Iga T. A comparative pharmacodynamic study of the arrhythmogenicity of antidepressants, fluvoxamine and imipramine, in guinea pigs. Biol Pharm Bull 24 (2001) 550-554